Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v3.20.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2019
Dec. 31, 2018
Current assets    
Cash and cash equivalents $ 20,528 $ 18,050
Investments 8,203 3,043
Accounts receivable 65 5
Inventory 1,014 23
Prepaid expenses and other current assets 339 930
Related party receivable 18
Total current assets 30,167 22,051
Fixed assets, net 1,056 846
Right-of-use assets 1,021
Other non-current assets 13 57
Total assets 32,257 22,954
Current liabilities    
Accounts payable and accrued expenses 2,999 2,140
Operating lease liabilities - current 321
Other current liabilities 270 253
Term debt, net of debt discount of $246 and $0, respectively 7,754
Total current liabilities 11,344 2,393
Contingent royalty obligation 1,872 1,953
Operating lease liabilities - non-current 713
Other non-current liabilities 91
Total liabilities 13,929 4,437
Commitments and contingent liabilities (Note 7)
Shareholders' equity    
Common Stock $0.0001 par value; 50,000,000 shares authorized; 28,811,087 and 21,440,148 shares issued and outstanding as of December 31, 2019 and December 31, 2018, respectively 3 2
Additional paid-in capital 102,789 79,893
Accumulated deficit (84,464) (61,378)
Total shareholders' equity 18,328 18,517
Total liabilities and shareholders' equity 32,257 22,954
Preferred Series A Stock [Member]    
Shareholders' equity    
Preferred Stock